Daré Bioscience, Inc. – NASDAQ:DARE

Daré Bioscience stock price today

$2.06
-1.21
-37%
Financial Health
0
1
2
3
4
5
6
7
8
9

Daré Bioscience stock price monthly change

-11.14%
month

Daré Bioscience stock price quarterly change

-11.14%
quarter

Daré Bioscience stock price yearly change

+867.46%
year

Daré Bioscience key metrics

Market Cap
27.75M
Enterprise value
48.42M
P/E
-2.64
EV/Sales
N/A
EV/EBITDA
N/A
Price/Sales
N/A
Price/Book
7.43
PEG ratio
N/A
EPS
-0.30
Revenue
N/A
EBITDA
-28.49M
Income
-28.87M
Revenue Q/Q
N/A
Revenue Y/Y
-99.97%
Profit margin
-309.25%
Oper. margin
-313.62%
Gross margin
0%
EBIT margin
-313.62%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Daré Bioscience stock price history

Daré Bioscience stock forecast

Daré Bioscience financial statements

Average Price Target
Last Year

$12

Potential upside: 482.52%

Based on estimate of 1 analysts
  • Analysts Price target

  • Financials & Ratios estimates

Daré Bioscience, Inc. (NASDAQ:DARE): Profit margin
Jun 2023 0 -8.76M
Sep 2023 1M -8.29M -829.91%
Dec 2023 1.80M -5.05M -279.75%
Mar 2024 9.30K -6.75M -72622.62%
0%
Yield TTM
Daré Bioscience, Inc. (NASDAQ:DARE): Payout ratio
Payout ratio 0%
Daré Bioscience, Inc. (NASDAQ:DARE): Dividend Yield
2019 6180.9%
2020 17.02%
2021
2022
2023
Daré Bioscience, Inc. (NASDAQ:DARE): Debt to assets
Jun 2023 23209954 25.92M 111.72%
Sep 2023 25054030 27.34M 109.14%
Dec 2023 21282215 26.32M 123.72%
Mar 2024 13012722 24.01M 184.53%
Daré Bioscience, Inc. (NASDAQ:DARE): Cash Flow
Jun 2023 -6.58M 0 452.19K
Sep 2023 -7.97M -22.09K 8.57M
Dec 2023 -8.17M -607.33K 5.30M
Mar 2024 -6.82M -7.29K 21.70K

Daré Bioscience alternative data

Daré Bioscience, Inc. (NASDAQ:DARE): Employee count
Aug 2023 25
Sep 2023 25
Oct 2023 25
Nov 2023 25
Dec 2023 25
Jan 2024 25
Feb 2024 25
Mar 2024 25
Apr 2024 25
May 2024 23
Jun 2024 23
Jul 2024 23

Daré Bioscience other data

1.90% -6.37%
of DARE is owned by hedge funds
1.60M -5.40M
shares is hold by hedge funds

Daré Bioscience, Inc. (NASDAQ:DARE): Insider trades (number of shares)
Period Buy Sel
Jun 2018 140000 0
Apr 2019 454545 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
HAWLEY ROGER director
Common stock 454,545 $1.1 $500,000
Purchase
HAWLEY ROGER director
Common stock 140,000 N/A N/A
Purchase
WALT DAVID R director Common Stock 591 $2.09 $1,234
Purchase
WALT DAVID R director Common Stock 1,700 $2.08 $3,529
Purchase
WALT DAVID R director Common Stock 4,500 $2.09 $9,401
Purchase
WALT DAVID R director Common Stock 4,460 $2.12 $9,442
Purchase
WALT DAVID R director Common Stock 4,500 $2 $9,014
Purchase
WALT DAVID R director Common Stock 4,311 $2 $8,631
Purchase
WALT DAVID R director Common Stock 4,350 $2.03 $8,835
Purchase
WALT DAVID R director Common Stock 4,500 $2.08 $9,338
Thursday, 14 November 2024
seekingalpha.com
zacks.com
globenewswire.com
Thursday, 7 November 2024
zacks.com
globenewswire.com
Wednesday, 23 October 2024
globenewswire.com
Monday, 21 October 2024
globenewswire.com
Monday, 12 August 2024
seekingalpha.com
zacks.com
globenewswire.com
Friday, 19 July 2024
globenewswire.com
Monday, 1 July 2024
newsfilecorp.com
Thursday, 27 June 2024
globenewswire.com
Tuesday, 14 May 2024
seekingalpha.com
globenewswire.com
Thursday, 2 May 2024
globenewswire.com
Tuesday, 30 April 2024
globenewswire.com
Tuesday, 23 April 2024
globenewswire.com
Thursday, 11 April 2024
globenewswire.com
Thursday, 28 March 2024
Seeking Alpha
Thursday, 21 March 2024
GlobeNewsWire
Thursday, 9 November 2023
Seeking Alpha
Thursday, 3 August 2023
GlobeNewsWire
Thursday, 13 July 2023
Proactive Investors
Tuesday, 11 July 2023
GlobeNewsWire
Thursday, 11 May 2023
Seeking Alpha
Thursday, 4 May 2023
GlobeNewsWire
Thursday, 30 March 2023
Seeking Alpha
Thursday, 23 March 2023
GlobeNewsWire
Wednesday, 1 March 2023
GlobeNewsWire
  • What's the price of DarĂ© Bioscience stock today?

    One share of DarĂ© Bioscience stock can currently be purchased for approximately $2.06.

  • When is DarĂ© Bioscience's next earnings date?

    Unfortunately, Daré Bioscience's (DARE) next earnings date is currently unknown.

  • Does DarĂ© Bioscience pay dividends?

    No, Daré Bioscience does not pay dividends.

  • How much money does DarĂ© Bioscience make?

    Daré Bioscience has a market capitalization of 27.75M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 71.92% to 2.81M US dollars.

  • What is DarĂ© Bioscience's stock symbol?

    Daré Bioscience, Inc. is traded on the NASDAQ under the ticker symbol "DARE".

  • What is DarĂ© Bioscience's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of DarĂ© Bioscience?

    Shares of Daré Bioscience can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are DarĂ© Bioscience's key executives?

    Daré Bioscience's management team includes the following people:

    • Ms. Sabrina Martucci Johnson Pres, Chief Executive Officer, Sec. & Director(age: 58, pay: $563,740)
    • Mr. John A. Fair Chief Strategy Officer(age: 54, pay: $453,610)
    • Ms. Lisa Walters-Hoffert Chief Financial Officer(age: 66, pay: $400,320)
  • How many employees does DarĂ© Bioscience have?

    As Jul 2024, Daré Bioscience employs 23 workers, which is 8% less then previous quarter.

  • When DarĂ© Bioscience went public?

    Daré Bioscience, Inc. is publicly traded company for more then 11 years since IPO on 10 Apr 2014.

  • What is DarĂ© Bioscience's official website?

    The official website for Daré Bioscience is darebioscience.com.

  • Where are DarĂ© Bioscience's headquarters?

    DarĂ© Bioscience is headquartered at 3655 Nobel Drive, San Diego, CA.

  • How can i contact DarĂ© Bioscience?

    DarĂ© Bioscience's mailing address is 3655 Nobel Drive, San Diego, CA and company can be reached via phone at 858 926 7655.

  • What is DarĂ© Bioscience stock forecast & price target?

    Based on 1 Wall Street analysts` predicted price targets for Daré Bioscience in the last 12 months, the avarage price target is $12. The average price target represents a 482.52% change from the last price of $2.06.

Daré Bioscience company profile:

Daré Bioscience, Inc.

darebioscience.com
Exchange:

NASDAQ

Full time employees:

23

Industry:

Biotechnology

Sector:

Healthcare

Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in female patients 12 years of age and older. Its products in advanced clinical development include Ovaprene, a hormone-free monthly vaginal contraceptive; and Sildenafil Cream, a cream formulation of sildenafil for topical administration to the vulva and vagina for treatment of female sexual arousal disorder. The company's Phase 1-ready products are DARE-HRT1, a combination of bio-identical estradiol and progesterone intravaginal ring for the treatment of vasomotor symptoms in hormone therapy; DARE-VVA1, a vaginally delivered formulation of tamoxifen to treat vulvar and vaginal atrophy in patients with hormone-receptor positive breast cancer; and DARE-FRT1, an intravaginal ring containing bio-identical progesterone for the prevention of preterm birth and broader luteal phase support as part of an in vitro fertilization treatment plan, as well as DARE-PTB1, an intravaginal ring containing bio-identical progesterone for the prevention of preterm birth. Its products in pre-clinical stage include DARE-LARC1, a combination product designed to provide reversible contraception; ADARE-204 and ADARE-214, an injectable formulations of etonogestrel to provide contraception over 6-month and 12-month periods; and DARE-RH1, a non-hormonal contraception for men and women. The company entered into license agreement with Organon & Co. and Organon International GmbH to commercialize XACIATO. Daré Bioscience, Inc. is headquartered in San Diego, California.

3655 Nobel Drive
San Diego, CA 92122

CIK: 0001401914
ISIN: US23666P1012
CUSIP: 23666P101